PALISADE BIO, INC. — Investor Relations & Filings
Filings indexed
1,045
across all filing types
Latest filing
2026-05-12
Regulatory Filings
Country
US
United States of America
Listing
US
PALI
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company that develops and advances novel therapeutics for patients with autoimmune, inflammatory, and fibrotic diseases. The company focuses on next-generation precision therapies, utilizing its phosphodiesterase-4 (PDE4) inhibitor prodrug platform. This platform is engineered to enable the targeted, oral delivery of therapeutics specifically to the gastrointestinal tract, aiming to enhance efficacy at the disease site while minimizing systemic side effects. Its lead development candidate, PALI-2108, is an oral PDE4 inhibitor prodrug being investigated for the treatment of inflammatory bowel diseases like ulcerative colitis.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-3 - PALISADE BIO, INC. (0001357459) (Filer) | 2026-05-12 | English | |
| 10-Q - PALISADE BIO, INC. (0001357459) (Filer) | 2026-05-12 | English | |
| ARS - PALISADE BIO, INC. (0001357459) (Filer) | 2026-04-29 | English | |
| 8-K - PALISADE BIO, INC. (0001357459) (Filer) | 2026-04-02 | English | |
| 10-K - PALISADE BIO, INC. (0001357459) (Filer) | 2026-03-20 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 45341987 | S-3 - PALISADE BIO, INC. (0001357459) (Filer) | 2026-05-12 | English | ||
| 45339305 | 10-Q - PALISADE BIO, INC. (0001357459) (Filer) | 2026-05-12 | English | ||
| 38828586 | ARS - PALISADE BIO, INC. (0001357459) (Filer) | 2026-04-29 | English | ||
| 33156249 | 8-K - PALISADE BIO, INC. (0001357459) (Filer) | 2026-04-02 | English | ||
| 33002255 | 10-K - PALISADE BIO, INC. (0001357459) (Filer) | 2026-03-20 | English | ||
| 29064240 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29064235 | 4 Filing | 2026-02-13 | English | ||
| 29064230 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 29064204 | 4 Filing | 2026-02-13 | English | ||
| 29064219 | 4 Filing | 2026-02-11 | English | ||
| 29064206 | 4 Filing | 2026-02-11 | English | ||
| 29064260 | SCHEDULE 13G Filing | 2026-02-10 | English | ||
| 29064212 | 4 Filing | 2026-01-21 | English | ||
| 29064249 | 4 Filing | 2026-01-13 | English | ||
|
2025
1 filing
| |||||
| 11961042 | 8-K | 2025-12-04 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Altimmune, Inc.
Clinical-stage biopharma developing peptide therapeutics fo…
|
ALT | US | Manufacturing |
|
Alto Neuroscience, Inc.
Develops precision medicines for neuropsychiatric condition…
|
ANRO | US | Manufacturing |
|
ALUMIS INC.
Clinical-stage biopharma developing precision medicines for…
|
ALMS | US | Manufacturing |
|
Alvotech Holdings S.A
A biotechnology company developing and manufacturing biosim…
|
ALVO | LU | Manufacturing |
|
ALX ONCOLOGY HOLDINGS INC
Clinical-stage immuno-oncology company developing therapies…
|
ALXO | US | Manufacturing |
|
Alzamend Neuro, Inc.
Develops treatments for neurodegenerative diseases and psyc…
|
ALZN | US | Manufacturing |
|
Alzinova AB
Clinical-stage biopharma developing immunotherapies for Alz…
|
ALZ | SE | Manufacturing |
|
Amanta Healthcare Limited
Manufactures sterile liquid formulations using advanced Blo…
|
AMANTA | IN | Manufacturing |
|
AMARIN CORP PLC\UK
Develops and commercializes therapeutics to improve cardiov…
|
AMRN | US | Manufacturing |
|
Ambalal Sarabhai Enterprise Ltd.
Manufactures pharmaceuticals, APIs, fine chemicals, and dia…
|
AMBALALSA | IN | Manufacturing |
PALISADE BIO, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35274/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35274 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35274 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35274 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35274}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PALISADE BIO, INC. (id: 35274)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.